cas9
 
        Broad Institute maintains patents to Gene Scissors in the US
By Joanna Applequist | Posted on February 17, 2017
The CRISPR-Cas9 technology, the so called “gene scissors” which allow for targeted genome-editing, is subject to a patent dispute between two research teams lead by Jennifer Doudna at UC Berkeley and Emanuelle Charpentier then at the University of Vienna on one hand, and Feng Zhang’s lab at the Broad Institute and MIT on the other....
Tags: cas9, crispr, crispr-cas9
Recent contributors
 
            
            
            Partner, European Patent Attorney
 
            
            
            Senior Associate, Attorney at Law
 
            
            
            Partner, Attorney at Law, Group Vice President
 
            
            
            Partner, Attorney at Law, Business Area Manager
 
            
            
            Senior Counsel, European Patent Attorney
 
       
                      